Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-J4 Hydrochloride (GSK J4 HCl) 是 H3K27me3/me2 去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 双抑制剂,IC50分别为 8.6 和 6.6 μM。它是 GSK-J1 的乙酯衍生物,体外 IC50 值大于 50 μM。它抑制 LPS 诱导的人原代巨噬细胞产生 TNF-α,IC50值为 9 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 266 | 现货 | ||
2 mg | ¥ 378 | 现货 | ||
5 mg | ¥ 622 | 现货 | ||
10 mg | ¥ 955 | 现货 | ||
25 mg | ¥ 1,960 | 现货 | ||
50 mg | ¥ 3,730 | 现货 | ||
100 mg | ¥ 4,790 | 现货 | ||
200 mg | ¥ 6,590 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,090 | 现货 |
产品描述 | GSK-J4 Hydrochloride (GSK J4 HCl) is a cell permeable, potent and selective histone demethylase(JMJD3 )inhibitor. is an ethyl ester derivative of the GSK-J1 with an IC50 value greater than 50 μM in vitro. |
靶点活性 | JMJD3:50 μM, JMJD3 (cell-free assay):60 nM |
体外活性 | When administered to human primary macrophages, GSK-J4 can reduce LPS-induced proinflammatory cytokine production, most notably including that of TNFα (IC50 = 9 μM). |
体内活性 | Acting as a prodrug, GSK-J4 is rapidly hydrolyzed in cells to the otherwise cell impermeable GSK-J1, which exhibits an IC50 value of 60 nM for the purified enzyme. The histone H3 lysine 27 (H3K27) demethylase JMJD3 plays important roles in the transcriptional regulation of cell differentiation, development, the inflammatory response, and cancer. |
别名 | GSK J4 HCl, GSK J4 HCl (1373423-53-0 free base) |
分子量 | 453.97 |
分子式 | C24H28ClN5O2 |
CAS No. | 1797983-09-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 20 mg/mL
DMSO: 50 mg/mL (110.14 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.2028 mL | 11.0139 mL | 22.0279 mL | 55.0697 mL |
5 mM | 0.4406 mL | 2.2028 mL | 4.4056 mL | 11.0139 mL | |
10 mM | 0.2203 mL | 1.1014 mL | 2.2028 mL | 5.507 mL | |
20 mM | 0.1101 mL | 0.5507 mL | 1.1014 mL | 2.7535 mL | |
50 mM | 0.0441 mL | 0.2203 mL | 0.4406 mL | 1.1014 mL | |
100 mM | 0.022 mL | 0.1101 mL | 0.2203 mL | 0.5507 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GSK-J4 Hydrochloride 1797983-09-5 Chromatin/Epigenetic Histone Demethylase GSK J4 HCl diabetic Th17 mice cells inflammation Th1 H3K27me3/me2 dendritic GSKJ4 Hydrochloride TGF-β 1373423-53-0 inhibit 1373423-53-0 free base Inhibitor GSK J4 Hydrochloride GSK J4 HCl (1373423-53-0 free base) demethylase GSK-J4 GSK-J-4 Hydrochloride inhibitor